• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 20-F filed by TIAN RUIXIANG Holdings Ltd

    3/4/26 6:03:53 AM ET
    $TIRX
    Specialty Insurers
    Finance
    Get the next $TIRX alert in real time by email
    NT 20-F 1 tm2531633d2_nt20f.htm FORM NT 20-F

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 12b-25

     

    NOTIFICATION OF LATE FILING

     

    (Check One): ¨ Form 10-K x Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-CEN ¨ Form N-CSR

     

    For Period Ended: October 31, 2025

     

    ¨ Transition Report on Form 10-K

    ¨ Transition Report on Form 20-F

    ¨ Transition Report on Form 11-K

    ¨ Transition Report on Form 10-Q

     

    For the Transition Period Ended: _____________________________________

     

    Read Instruction (on back page) Before Preparing Form. Please Print or Type.

     

    NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS VERIFIED

    ANY INFORMATION CONTAINED HEREIN.

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

    PART I -- REGISTRANT INFORMATION

     

    Full Name of Registrant: TIAN RUIXIANG Holdings Ltd
    Former Name if Applicable: N/A
    Address of Principal Executive Office
    (Street and Number):
    2107, Block B, Shoudong International
    Dongcheng District
    City, State and Zip Code: Beijing, People’s Republic of China 100000

     

     

     

     

     

    PART II - RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed (Check box if appropriate)

     

    x (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
    x (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
      (c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III -- NARRATIVE

     

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

     

    TIAN RUIXIANG Holdings Ltd (the “Registrant”) was unable, without unreasonable effort or expense, to file its Annual Report on Form 20-F for the fiscal year ended October 31, 2025 (the “Annual Report”) by the due date, due to a delay experienced by the Registrant in completing its financial statements and other disclosures in the Annual Report. The Registrant is working diligently to complete the Annual Report and expects to file the Annual Report within the 15-calendar day extension provided by Rule 12b-25, but can provide no assurance that it will be able to file by such time.

     

     2 

     

     

    PART IV -- OTHER INFORMATION

     

    (1) Name and telephone number of person to contact in regard to this notification:

     

    Yue Wang   (86)   18210969385
    (Name)   (Area Code)   (Telephone Number)

     

    (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

     

    x Yes ¨ No

     

    (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

     

    x Yes ¨ No

     

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

    The Company anticipates reporting an increase in revenue for the fiscal year ended October 31, 2025, compared to approximately $3.22 million for the fiscal year ended October 31, 2024. This increase is primarily driven by the expansion of the Company's insurance brokerage activities and recent business developments, including the impact of recent acquisitions.

     

    However, the Company also anticipates a substantial increase in operating expenses. This increase is primarily attributable to higher legal and professional fees associated with the Company’s efforts to maintain its Nasdaq listing and the related appeal of a delisting notification, as well as costs incurred in connection with the transition of the Company’s independent registered public accounting firm following the dismissal of its previous auditor in August 2025.

     

     3 

     

     

      TIAN RUIXIANG Holdings Ltd  
      (Name of Registrant as Specified in Charter)  

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: March 4, 2026 By: /s/ Baohai Xu
        Baohai Xu
        Chief Executive Officer

     

     4 

     

    Get the next $TIRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TIRX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $TIRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TIAN RUIXIANG UNLEASHING HISTORIC CATALYSTS: 1:50 REVERSE SPLIT MARCH 16; DUE DILIGENCE COMPLETED FOR 30,000 BITCOIN INFUSION AND AI INSURANCE BROKERAGE ACQUISITION, TARGETED CLOSING IN Q2–Q3 2026

    BEIJING, March 03, 2026 (GLOBE NEWSWIRE) -- Tian Ruixiang Holdings Limited (NASDAQ:TIRX) today announces a seismic, paradigm-shifting set of catalysts designed to ignite explosive growth, redefine its market valuation, and deliver unprecedented shareholder value. The Company confirms its 1:50 reverse stock split will be fully effective March 16, 2026, marking a critical milestone to strengthen liquidity, institutional eligibility, and long-term price momentum. In a landmark development, TIRX has successfully completed full due diligence for two transformative transactions: - A strategic corporate treasury infusion of 30,000 Bitcoin; - The acquisition of a high-growth AI-powered insuran

    3/3/26 9:30:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd. Announces Expected Effective Date for Previously Announced 1-for-50 Reverse Stock Split

    BEIJING, Feb. 27, 2026 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd. (NASDAQ:TIRX) (the "Company") today announced an update regarding its previously announced 1-for-50 reverse stock split (the "Reverse Split") of its ordinary shares. As previously announced on February 18, 2026, following the results of the Company's annual general meeting of shareholders held on February 17, 2026, the Company's Board of Directors approved the implementation of the Reverse Split. The Company now expects the Reverse Split to become effective for trading purposes on the Nasdaq Capital Market ("Nasdaq") during the week of March 16, 2026, pending final processing by Nasdaq. The Company's Class A ordinary

    2/27/26 9:00:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG REVEALS HISTORIC 30,000 BTC STRATEGIC INJECTION: DOUBLING DOWN ON AI-CRYPTO DOMINANCE AMID MARKET TURBULENCE

    Beijing, Feb. 26, 2026 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd. (NASDAQ:TIRX) ("the Company"), a trailblazer at the intersection of artificial intelligence (AI) and cryptocurrency, today announced a seismic escalation of its landmark strategic partnership, doubling the planned Bitcoin (BTC) injection from 15,000 to an unprecedented 30,000 BTC. This bold revision, forged with its elite global digital asset strategic investor amid recent market volatility, underscores unshakable confidence in TIRX's vision and positions the Company to seize transformative opportunities in the evolving AI-crypto landscape. Against the backdrop of recent market corrections, the strategic investor—reno

    2/26/26 9:00:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    SEC Filings

    View All

    SEC Form NT 20-F filed by TIAN RUIXIANG Holdings Ltd

    NT 20-F - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    3/4/26 6:03:53 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    2/27/26 9:15:43 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    2/18/26 12:10:12 PM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Leadership Updates

    Live Leadership Updates

    View All

    TIAN RUIXIANG Holdings Ltd to Acquire Ucare Inc. in US$150 Million All-Stock Deal, Advancing In-Hospital Health Insurance Strategy

    BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. This strategic move aims to unlock new growth opportunities in the health insurance segment. The Company and its wholly-owned subsidiary, VitaCare Limited ("VitaCare") have entered into a share exchange agreement (the "Agreement") with certain shareholders (the "Sellers") of Ucare and other parties.

    5/30/25 6:10:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by TIAN RUIXIANG Holdings Ltd

    SC 13G/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    11/13/24 11:16:48 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form SC 13D filed by TIAN RUIXIANG Holdings Ltd

    SC 13D - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    6/10/24 6:15:45 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form SC 13D/A filed by TIAN RUIXIANG Holdings Ltd (Amendment)

    SC 13D/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    6/10/24 6:08:20 AM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Financials

    Live finance-specific insights

    View All

    Water Tower Research Publishes Initiation of Coverage Report on Tian Ruixiang Holdings Limited, "From Traditional Insurance Broker to Tech-Based Health Insurance Innovator"

    ST. PETERSBURG, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Tian Ruixiang Holdings Limited (NASDAQ:TIRX) titled, "From Traditional Insurance Broker to Tech- Based Health Insurance Innovator". The report can be accessed here. Access to China's growing health insurance market. On June 30, 2025, Chinese insurance broker Tian Ruixiang Holdings Limited completed the acquisition of Ucare, which describes itself as the only cloud-based healthcare value assessment and insurance risk control SaaS platform in China, for total all-stock consideration of $150 million. Ucare's wealth of AI-driven analytics st

    8/7/25 12:00:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd Completes Acquisition of Ucare Inc., Marking Strategic Expansion into AI-Powered Health Insurance Solutions

    BEIJING, June 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced it has completed the acquisition of 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform. The all-stock transaction, valued at US$150 million, marks a major milestone in TRX's strategy to expand into in-hospital distribution channels and capture new growth opportunities within the health insurance sector. As part of the closing, TRX has issued 101,486,575 Class A ordinary shares, each with a par value of US$0.025

    6/30/25 3:05:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd Reports Financial Results for the Half Year Ended April 30, 2024

    BEIJING, Aug. 16, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced its financial results for the half year ended April 30, 2024. Ms. Sheng Xu, the Chief Executive Officer of the Company, commented, "The Company reported a net loss of approximately $2.6 million for the six months ended April 30, 2024, primarily due to a significant decline in revenue caused by the loss of a few key insurance company partners. However, we are encouraged by the increase in the commissions from liability insurance of approximately $24,000 compared to t

    8/16/24 4:15:15 PM ET
    $TIRX
    Specialty Insurers
    Finance